Dependence of the hazard of AIDS on markers

AIDS

Volumn 11, Issue 2, 1997, Pages 217-228

  Yong, Florence H L ^a   Taylor, Jeremy M G ^b   Bryant, John L ^c   Chmiel, Joan S ^d   Gange, Stephen J ^e   Hoover, Donald ^e  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; CD4 T lymphocyte cell counts; Hazard; HIV; Kernel smoothing; Non parametric; Serum activation markers

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; NEOPTERIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE MARKER; HAZARD; HUMAN; IMMUNE FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPTERIN; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HOMOSEXUALITY, MALE; HUMANS; MALE; NEOPTERIN; TIME FACTORS;

EID: 0031029006     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199702000-00013     Document Type: Article

References (24)

1. Lang W, Perkins H, Anderson RE, Royce R, Jewell NP, Winkelstein W Jr: Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989, 2:63-69.
2. Fahey JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990, 322:166-172.
3. Goedert JJ, Kessler CM, Aledort LM, et al.: A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989, 321:1141-1148.
4. Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo, BS, Kokka, RP, Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
5. O'Brien TR, Blattner WA, Waters D, et al: Serum HIV-1 RNA levels and time to the development of AIDS in the multicenter Hemophilia Cohort Study. J Am Med Assoc 1996, 276:105-110.
6. Brookmeyer R, Gail MH: Biases in prevalent cohorts. Biometrics 1987, 43:739-749.
7. Jewell NP, Kalbfleisch JD: Marker models in survival analysis and applications to issues associated with AIDS. In AIDS Epidemiology: Methodological Issues. Edited by Jewell NP, Dietz K, Farewell VT. Boston: Birkhauser; 1992:211-230.
8. Jewell NP, Nielsen JP: A framework for consistent prediction rules based on markers. Biometrika 1993, 80:153-164.
9. DeGruttola V, Lange N, Dafni R: Modeling the progression of HIV infection. J Am Stat Assoc 1991, 86:569-577.
10. Taylor JMG, Cumberland WG, Sy JP: A stochastic model for analysis of longitudinal AIDS data. J Am Stat Assoc 1994, 89:727-736.
11. Longini IM Jr, Clark WS, Byers RH, et al: Statistical analysis of the stages of HIV infection using a Markov model. Stat Med 1989, 8:831-843.
12. Shi M, Taylor JMG, Currier RJ, et al: Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. J Acquir Immune Defic Syndr 1996, 12:309-316.
13. Phillips AN, Sabin CA, Elford J, Bofill M, Janossy G, Lee CA: Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts. Am J Epidemiol 1993, 138:870-878.
14. Phillips AN, Pezzotti P, Lepri AC, Rezza G, the Italian Seroconversion Study: CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study. AIDS 1994, 8:1299-1305.
15. Fusaro RE, Nielsen JP, Scheike TH: Marker-dependent hazard estimation: an application to AIDS. Stat Med 1993, 12:843-865.
16. Taylor JMG, Chon Y: Semi-parametric estimation of the incubation period of AIDS. In AIDS Epidemiology: Methodological Issues. Edited by Jewell NP, Dietz K, Farewell VT. Boston: Birkhauser; 1992:335-349.
17. Rosenberg PS, Goedert JJ, Biggar RJ, the Multicenter Hemophilia Cohort Study, the International Registry of Seroconverters: Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994, 8:803-810.
18. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR: Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Nature 1996, 347:1573-1579.
19. Taylor JMG, Sy JP, Visscher B, Giorgi JV: CD4+ T-cell number at the time of acquired immunodeficiency syndrome. Am J Epidemiol 1995, 141:645-651.
20. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr: The Multicenter AIDS Cohort Study: rationale, organization and selected characteristics of the participants. Am J Epidemiol 1987, 126:310-318.
21. Cleveland WS: Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979, 74:829-836.
22. Darby SC, Doll R, Thakrar B: Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat Med 1990, 9:681-689.
23. Veugelers PJ, Page KA, Tindall B, et al.: Determinants of HIV disease progression among homosexual men registered in the tricontinental seroconverter study. Am J Epidemiol 1994, 140:747-758.
24. Tsiatis AA, DeGruttola V, Wulfsohn MS: Modeling the relationship of survival to longitudinal data measured with error. Applications to survival and CD4 counts in patients with AIDS. J Am Stat Assoc 1995, 90:27-37.